Bedtime diazepam enhances well-being in children with spastic cerebral palsy

Anna Mathew1, M C Mathew

  • 1Continuing Medical Education Department, Christian Medical College, Vellore, T.Nadu, India. ashirvad@cmcvellore.ac.in

Pediatric Rehabilitation
|April 1, 2005
PubMed

Insights

Bedtime diazepam significantly improved the behavior and daily living activities of children with cerebral palsy by reducing muscle spasms. This treatment also lessened family care burdens without causing daytime sedation.

Area of Science:

  • Pediatric Neurology
  • Rehabilitation Medicine
  • Clinical Pharmacology

Background:

  • Children with cerebral palsy often experience hypertonia and muscle spasms, leading to distress and resistance to physical therapy.
  • Managing these symptoms is crucial for improving quality of life and reducing caregiver burden.

Purpose of the Study:

  • To evaluate the efficacy of a single bedtime dose of diazepam in conjunction with passive stretching exercises for children with cerebral palsy.
  • To assess the impact of this intervention on child behavior, daily living activities, and nighttime wakefulness.

Main Methods:

  • A double-blind, placebo-controlled, randomized clinical trial was conducted.
  • Participants received either a bedtime dose of diazepam or a placebo, combined with passive stretching exercises.

Main Results:

  • Bedtime diazepam significantly improved child behavior and facilitated passive stretching by reducing hypertonia and muscle spasms.
  • Children experienced enhanced well-being during daily activities, reduced crying spells, and less nighttime wakefulness.
  • No daytime sedation was observed as an adverse effect.

Conclusions:

  • A single bedtime dose of diazepam, when combined with passive stretching, is an effective strategy for managing spasticity in children with cerebral palsy.
  • This approach improves functional abilities, reduces behavioral issues, and alleviates the burden on families.

Related Concept Videos

Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...